What Musely does

Musely is a direct-to-consumer telemedicine platform that delivers prescription-strength compounded treatments for dermatology, hair loss, menopause/hormone replacement, and longevity indications. The company operates an asynchronous care model in which patients complete online consultations reviewed by board-certified dermatologists and OB-GYNs, then receive freshly compounded prescription formulations shipped directly to their door on a recurring subscription basis. The product portfolio spans over 20 active prescription SKUs including The Spot Cream, The Cell Repair Serum (which incorporates iPSC-derived exosomes at 250M to 1B per bottle and 0.0125% Rapamycin), The Age Well Pill (a longevity oral combining Metformin, Fisetin, CoQ10, Ca-AKG, and Nicotinamide Riboside), and a full HRT lineup (Estrogen Patch/Cream/Pill, Progesterone Pill). All treatments are produced in Musely's proprietary 503A compounding pharmacies, a vertical integration that distinguishes it from pure telehealth resellers.

The underlying platform pairs a photo-based skin analysis workflow with a recommendation engine that routes patients to condition-specific compounds, supported by a mobile app that offers progress tracking and community features. Pricing is subscription-based at $20-$99/month per product, with free shipping, HSA/FSA support, and a 60-Day Result Guarantee on select treatments. Distribution is exclusively DTC through musely.com and the Musely iOS/Android app, with no retail or third-party channels, and the company serves an exclusively US customer base of more than 1.2 million patients. Customer acquisition combines paid social/search, organic content, a community of 1M+ users, and large promotional events (e.g., a Super Bowl Sunday 60%-off promotion that drove 10-20x normal traffic and 300-400% higher conversion rates).

Musely generates revenue through recurring monthly subscriptions, supplemented by a small base of non-prescription essentials (Cleanser, Day Cream, Vitamin C Serum). The company reports nine-figure revenue, 50% year-over-year revenue growth, 95% patient satisfaction, and retention rates 2-3x higher than industry peers, and it is cash-flow positive. In May 2026, Musely secured over $360 million in non-dilutive revenue-share financing from General Catalyst's Customer Value Fund, bringing total known funding above $380 million while preserving founder/CEO Jack Jia's ownership. The company has been recognized as the #1 fastest-growing tele-dermatology company on the Inc. 5000 and as Ad Age's 2025 Breakout Brand Leader.

Name

Musely

Legal name

Musely

Website

https://musely.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Musely is a direct-to-consumer telemedicine platform that delivers prescription compounded skincare, hair loss, menopause, and longevity treatments via asynchronous consultations with board-certified dermatologists and OB-GYNs, shipping directly to US patients on a recurring subscription.

Ownership category

akta.pro rank

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain

Revenue model

1. Prescription Compounded Skincare Product Sales: Musely generates revenue through direct-to-consumer sales of prescription compounded skincare treatments sold on a subscription/refill basis. Patients pay monthly fees ranging from $20 to $99 per product for prescription treatments covering dermatology (acne, dark spots, anti-aging), hair loss, and menopause care. The company also sells non-prescription essentials (cleanser, day cream, vitamin C serum). Refills are automatic with savings on refills, free shipping, and HSA/FSA support. With over 1.2 million patients and ~50% year-over-year revenue growth, the company reports nine-figure annual revenue.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Musely operates a direct-to-consumer telemedicine platform that delivers prescription-strength compounded skincare, hair loss, menopause/HRT, and longevity treatments through asynchronous online consultations reviewed by board-certified dermatologists and OB-GYNs. Treatments are freshly compounded at Musely's proprietary pharmacies into customized formulations and shipped directly to patients on a recurring subscription basis at $20–$99 per product, supported by a 60-Day Result Guarantee, free shipping, and HSA/FSA payment support.

Product overview

Musely is a direct-to-consumer telemedicine platform offering prescription compounded skincare treatments and non-prescription essentials through asynchronous consultations with board-certified dermatologists and OB-GYNs. The product portfolio spans over 20+ prescription treatments organized into treatment categories: Dark Spot treatments (The Spot Cream, The Spot Pill, The Spot Peel), Anti-Aging treatments (The Anti-Aging Cream, The Aging Repair Cream, The Neck Cream, The Cell Repair Serum, The Eye Serum), Acne treatments (The Acne Cream), Body treatments (The Body Cream, The Private Cream, The KP Cream), Hair treatments (The Hair Pill, The Hair Topical Solutions Classic and Modern, The Facial Hair Cream, The Lash Serum), Menopause/HRT treatments (The Estrogen Patch, The Estrogen Cream, The Estrogen Pill, The Progesterone Pill), Redness/Rosacea treatments (The Red Set, The Red Rescue, The Rosacea Cream), Longevity (The Age Well Pill, The Skin Pill), plus non-prescription essentials (The Vitamin C Serum, The Cleanser, The Day Cream). Treatments are freshly compounded at pharmacies before shipping directly to customers.

Differentiator

Problem solved

Functional benefit

Products and services

• The Spot Cream Prescription-strength topical cream to treat dark spots on the face including melasma, sun/age spots, and acne scars, sold as a $36/month subscription (2-month supply).
• The Spot Pill Oral dark spot medication using tranexamic acid to treat melasma from within, sold as a $30/month subscription (2-month supply).
• The Spot Peel One-time fast-acting facial dark spot treatment peel for melasma, sun/age spots, and acne scars, sold at $99 per purchase.
• The Anti-Aging Cream Topical tretinoin cream treating fine lines, wrinkles, acne, large pores, and dull skin, sold as a $35/month subscription (2-month supply).
• The Aging Repair Cream Topical estrogen-based cream for women over 30 that plumps skin and restores elasticity, addressing loss of elasticity, menopausal skin, and wrinkles, sold as a $36/month subscription.
• The Neck Cream Topical cream treating signs of aging on the neck and chest including sun/age spots and wrinkles, sold as a $36/month subscription.
• The Cell Repair Serum Exosome-infused serum with iPSC Exosomes (250M or 1B per bottle) and Rapamycin 0.0125% that stimulates regenerative properties and increases cell turnover, sold as a $49/month subscription.
• The Eye Serum Prescription-strength eye serum with iPSC exosomes, tretinoin, caffeine, and hydroquinone targeting wrinkles, crow's feet, puffiness, and dark circles, sold as a $41/month subscription.
• The Acne Cream Prescription acne treatment cream with Tretinoin 0.015%, Clindamycin 0.75%, Niacinamide 4%, and Azelaic Acid 2% targeting acne, pustules, and uneven texture, sold as a $30/month subscription.
• The Body Cream Prescription dark spot cream for body treating hyperpigmentation, sun damage, and signs of aging on hands, arms, legs, feet, and back using Hydroquinone 12%, Tretinoin 0.01%, Glycolic Acid, and the Musely Micro Base delivery system, sold as a $49/month subscription.
• The Private Cream Topical dark spot treatment for intimate areas including underarm, inner thigh, and private area hyperpigmentation, sold as a $36/month subscription.
• The KP Cream Topical treatment for keratosis pilaris (chicken skin) on the body, sold as a $49/month subscription.
• The Red Set Pair of topical treatments for rosacea and redness including skin redness, blushing, and pustules, sold as a $62/month subscription.
• The Red Rescue Topical treatment that reduces redness and flushing for rosacea-prone skin, sold as a $36/month subscription.
• The Rosacea Cream Topical rosacea treatment reducing inflammation and redness, sold as a $41/month subscription; also available bundled with The Rosacea Pill at $98/month for severe flare-ups.
• The Hair Pill Oral minoxidil medication for hair loss and thinning available for both women and men, sold as a $32/month subscription.
• The Hair Topical Solution - Classic Topical minoxidil treatment for hair loss and thinning available for both women and men, sold as a $33/month subscription.
• The Hair Topical Solution - Modern Exosome-infused serum (iPSC exosomes) for thicker hair growth targeting thinning, bald spots, and receding hairline in women and men, sold as a $36/month subscription.
• The Facial Hair Cream Topical treatment that slows the growth of unwanted facial hair, sold as a $41/month subscription.
• The Lash Serum Topical solution for eyelash growth targeting short lashes, sold as a $33/month subscription.
• The Estrogen Patch Transdermal bioidentical estradiol HRT patch available in 0.025mg/day, 0.05mg/day, and 0.1mg/day dosages for menopause relief, sold as a $75/month subscription (50-day supply).
• The Estrogen Cream Topical HRT cream for menopause relief treating hair changes, skin changes, and nail changes, sold as a $46/month subscription.
• The Estrogen Pill Oral HRT for menopause relief addressing hot flashes, night sweats, and low energy, sold as a $35/month subscription.
• The Progesterone Pill Oral progesterone for menopause relief and uterine health addressing uterine lining issues, night sweats, and irregular cycles, sold as a $20/month subscription.
• The Age Well Pill Prescription oral medication for longevity supporting increased energy, cellular renewal, and healthy aging, combining Metformin, Fisetin, CoQ10, Ca-AKG, and Nicotinamide Riboside, sold as a $45/month subscription.
• The Skin Pill Daily oral treatment that repairs skin at the cellular level and protects against skin damage with Methylene Blue 1.5mg, Glutathione 500mg, and Polypodium Leucotomos 320mg, sold as a $38/month subscription.
• The Vitamin C Serum Non-prescription vitamin C serum for daily skincare maintenance.
• The Cleanser Non-prescription facial cleanser for daily skincare routine.
• The Day Cream Non-prescription daytime moisturizing cream.
• The Cleanser & Day Cream Bundle Bundle of The Cleanser and The Day Cream for a complete daily skincare routine.

Quantifiable outcome

• Customer acquisition cost funded through revenue-share financing without equity dilution, enabling sustainable growth investment
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Keeps: DTC telehealth subscription for men's hair loss (finasteride, minoxidil), with dermatology-adjacent offerings. Direct comparison to Musely's Hair Pill and Hair Topical Solution lines, though narrower in scope.
• Nurx: Telehealth platform (acquired by Thirty Madison) offering prescriptions for women's health, dermatology, and hair loss. Comparable in model — online consultation, prescription dispensed and shipped — and overlaps with Musely's skincare and women's wellness offerings.
• Curology: Direct competitor in prescription compounded skincare delivered via asynchronous online dermatology consultations, with personalized formulations for acne, anti-aging, and hyperpigmentation. Closest pure-play peer to Musely's dermatology core, now backed by Galderma.
• Ro: DTC telehealth company (formerly Roman) operating parallel verticals in men's and women's health, including dermatology, hair, and weight loss. Direct overlap with Musely's prescription dermatology, hair loss, and women's wellness/HRT stack.
• Evernow: DTC menopause care platform providing HRT prescriptions and ongoing physician support via telehealth. Compares to Musely's menopause stack — direct overlap in target demographic, condition focus, and asynchronous consult model.
• Apostrophe: Was a direct competitor in prescription compounded teledermatology for acne, rosacea, and anti-aging. Musely explicitly recruits displaced Apostrophe customers following its wind-down — making it both a former peer and a customer acquisition source.
• Winona: Direct-to-consumer menopause and HRT telehealth platform offering bioidentical hormone therapy through asynchronous physician consultations. Closest pure-play peer to Musely's menopause/HRT segment (Estrogen Patch, Estrogen Pill, Progesterone Pill).
• Hims & Hers Health: Public DTC telehealth platform offering prescription treatments across dermatology, hair loss, sexual health, and mental health. Directly overlaps with Musely in telehealth dermatology, hair loss (minoxidil, finasteride), and women's wellness, with broader category breadth.

Emerging players

• Alloy Women's Health: DTC telehealth platform focused on menopause and women's midlife health, offering HRT and hormone-related treatments. Closely comparable to Musely's menopause segment, though narrower in dermatology scope.
• Tia: Women's telehealth and in-person care provider with a focus on gynecology, primary care, and menopause. Overlaps with Musely's menopause/HRT segment but operates a hybrid in-person + virtual model rather than pure DTC telehealth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/musely
• LinkedInlinkedin.com/company/trusper-inc
• Instagraminstagram.com/musely
• TikToktiktok.com/@musely
• Facebookfacebook.com/muselyofficial

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds7 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Musely